BioCentury
ARTICLE | Clinical News

Xultophy insulin degludec/liraglutide: Additional Phase IIIb data

September 21, 2015 7:00 AM UTC

Additional data from the open-label, international Phase IIIb DUAL V trial in 557 Type II diabetics uncontrolled on Lantus insulin glargine showed that once-daily Xultophy as an add-on to metformin s...